Work

P2.03-052 Local Ablative Therapy for Oligoprogressive, EGFR-Mutant, Non-Small Cell Lung Cancer (NSCLC) After Treatment with Osimertinib

Year: 2017

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.09.1303

Authors: C. Kim, N. Roper, C. Hoang, M. Connolly, C. Cultraro, E. Szabo, M. Waris, E. Padiernos, A. Kesarwala, S. Gao, S. Steinberg, D. Wong, J. Khan, A. Rajan, U. Guha

Institutions: National Institutes of Health, National Cancer Institute, University of California, Los Angeles, Center for Cancer Research

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2767566740

FWCI:

Cites:

Cited by:

Related to: 10